A kind of synthetic method of riociguat intermediate

A synthesis method and intermediate technology, applied in the field of synthesis of riociguat intermediates, can solve problems such as high risk factor, difficult purification, and many impurities, and achieve the goals of reducing equipment requirements, increasing reaction yield, and simplifying process operations Effect

Active Publication Date: 2017-03-29
郑州大明药物科技有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] However, according to the above synthesis route, it is found in the actual synthesis process that this synthesis method has the following problems: in the second step process, catalytic hydrogenation under high pressure is required, the risk factor is high, and special high-pressure reaction equipment is required in industrial production, which is not conducive to industrialization Large-scale production, at the same time, the yield of the reaction product in this step is low, the content is low, and there are many impurities. Some impurities are easily brought to the final product, resulting in many new impurities in the final product and difficult purification; making this step a limit for the large-scale industrial production of riociguat main factor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of synthetic method of riociguat intermediate
  • A kind of synthetic method of riociguat intermediate
  • A kind of synthetic method of riociguat intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] a. Add 50.0g (0.16mol) 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamidine hydrochloride, 27.2 g (0.16mol) to a 500ml reaction flask mol) phenylpropazomalononitrile, 8.6g (0.16mol) sodium methoxide and 350ml DMF, stirred at 110°C for 12 hours, cooled to 25°C, filtered to obtain a solid, stirred and washed with 250ml of ethanol for 10min, and filtered to obtain a solid , and repeated the above washing steps twice to obtain a solid, which was dried in a drying oven at 85 °C for 5 h to obtain 60.7 g of compound III with a yield of 84.6%;

[0037] b. Add 60.7g (0.138mol) of compound III, 7.4g (0.138mol) of ammonium chloride and 730ml of ethanol / water into a 1 L reaction flask, add 5.8g (0.1mol) of iron powder under stirring, and heat at 79°C After stirring and reacting for 8 hours, cool down to 25°C, filter to obtain the filtrate, distill under reduced pressure (vacuum degree: 0.090 MPa, temperature: 65°C) to obtain the residue, add 120ml of water to the residue a...

Embodiment 2

[0039] a. Add 50.0g (0.16mol) 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamidine hydrochloride, 29.9 g (0.176 mol) phenylpropazomalononitrile, 21.8g (0.32mol) sodium ethoxide and 500ml DMF, stirred at 120°C for 15 h, cooled to 20°C, filtered to obtain a solid, stirred and washed with 250ml of ethanol for 10 min, filtered A solid was obtained, and the above washing steps were repeated twice to obtain a solid, which was placed in a drying oven at 80°C for 5 h to obtain 57.4 g of compound III, with a yield of 80.0%;

[0040]b. Add 57.4g (0.13mol) of compound III, 8.3g (0.156mol) of ammonium chloride and 860ml of ethanol / water into a 1L reaction flask, add 6.6g (0.117mol) of iron powder under stirring, and put After stirring and reacting for 10 h, cool down to 30 °C, filter to obtain the filtrate, distill under reduced pressure (vacuum degree: 0.090 MPa, temperature: 70 °C) to obtain the residue, add 120 ml of water to the residue and stir for 30 min, and filter to obta...

Embodiment 3

[0042] a. Add 50.0g (0.16mol) 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamidine hydrochloride, 33.4 g (0.196 mol) phenylpropazomalononitrile, 5.9g (0.245mol) sodium hydride and 250ml DMF, stirred at 115 °C for 10 h, cooled to 30 °C, filtered to obtain a solid, stirred and washed with 250 ml of ethanol for 10 min, and filtered to obtain a solid , and then repeated the above washing steps twice to obtain a solid, which was placed in a 90 °C drying oven for 5 h to obtain 59.8 g of compound III with a yield of 83.4%;

[0043] b. Add 59.8g (0.136mol) of compound III, 10.9g (0.2mol) of ammonium chloride and 598ml of medicinal ethanol / water into a 1L reaction flask, add 7.6g (0.136mol) of iron powder under stirring, and After stirring and reacting at ℃ for 6 hours, cool down to 20 ℃, filter to obtain the filtrate, distill under reduced pressure (vacuum degree: 0.090 MPa, temperature: 60 ℃) to obtain the residue from the filtrate, add 120ml of water to the residue and stir...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for compounding riociguat intermediate, firstly 1-(2-fluorine benzyl) 1H-pyrazolo [3, 4-b] pyridine-3-formamidine hydrochloride are used as starting materials, and 2-[1-(2-fluorine benzyl)-1 H- pyrazolo [3, 4-b] pyridine-3-yl]-4, 5, 6-pyrimidine triamine of the riociguat intermediate are prepared by catalyzing and hydrogenating in normal pressure through a catalyst. The method for compounding the riociguat intermediate is mild in reaction conditions, prevents using a high pressure reaction kettle, reduces process demands to equipment, enables product purity to be bigger than 99.0% at last, and is suitable for commercial process.

Description

technical field [0001] The invention belongs to the field of chemical synthesis, in particular to a method for synthesizing a riociguat intermediate. Background technique [0002] Riociguat is a drug used to treat pulmonary hypertension (PH), mainly for chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Name: N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5 -Pyrimidinyl]-N-methylcarbamate, the structural formula of which is shown below. [0003] [0004] In the synthetic method of disclosed riociguat, mostly through intermediate 2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-4,5 ,6-pyrimidinetriamine (compound Ⅳ) to synthesize riociguat. [0005] [0006] Using two nitrogen atoms on 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamidine hydrochloride as double nucleophiles, and phenyl azopropane Nitrile, directly synthesize pyrimidine ring under the condition of sodium methoxi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D471/04
CPCC07D471/04
Inventor 毛影朱赞梅段艳培罗峰毕天昊
Owner 郑州大明药物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap